Myosin light chain kinase accelerates vesicle endocytosis at the calyx of Held synapse

J Neurosci. 2014 Jan 1;34(1):295-304. doi: 10.1523/JNEUROSCI.3744-13.2014.

Abstract

Neuronal activity triggers endocytosis at synaptic terminals to retrieve efficiently the exocytosed vesicle membrane, ensuring the membrane homeostasis of active zones and the continuous supply of releasable vesicles. The kinetics of endocytosis depends on Ca(2+) and calmodulin which, as a versatile signal pathway, can activate a broad spectrum of downstream targets, including myosin light chain kinase (MLCK). MLCK is known to regulate vesicle trafficking and synaptic transmission, but whether this kinase regulates vesicle endocytosis at synapses remains elusive. We investigated this issue at the rat calyx of Held synapse, where previous studies using whole-cell membrane capacitance measurement have characterized two common forms of Ca(2+)/calmodulin-dependent endocytosis, i.e., slow clathrin-dependent endocytosis and rapid endocytosis. Acute inhibition of MLCK with pharmacological agents was found to slow down the kinetics of both slow and rapid forms of endocytosis at calyces. Similar impairment of endocytosis occurred when blocking myosin II, a motor protein that can be phosphorylated upon MLCK activation. The inhibition of endocytosis was not accompanied by a change in Ca(2+) channel current. Combined inhibition of MLCK and calmodulin did not induce synergistic inhibition of endocytosis. Together, our results suggest that activation of MLCK accelerates both slow and rapid forms of vesicle endocytosis at nerve terminals, likely by functioning downstream of Ca(2+)/calmodulin.

Keywords: capacitance; endocytosis; myosin; myosin light chain kinase; the calyx of Held; vesicle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Stem / drug effects
  • Brain Stem / enzymology*
  • Endocytosis / drug effects
  • Endocytosis / physiology*
  • Enzyme Inhibitors / pharmacology
  • Female
  • Male
  • Myosin-Light-Chain Kinase / antagonists & inhibitors*
  • Myosin-Light-Chain Kinase / metabolism*
  • Organ Culture Techniques
  • Rats
  • Rats, Sprague-Dawley
  • Synapses / drug effects
  • Synapses / enzymology*
  • Synaptic Vesicles / drug effects
  • Synaptic Vesicles / enzymology*

Substances

  • Enzyme Inhibitors
  • Myosin-Light-Chain Kinase